Back to Search
Start Over
Reduction in antidrug antibody levels after switching to rituximab in patients with rheumatoid arthritis with prior infliximab or adalimumab secondary failure.
- Source :
-
Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2020 Feb; Vol. 50 (1), pp. E1-E2. Date of Electronic Publication: 2019 Jun 28. - Publication Year :
- 2020
- Subjects :
- Adalimumab immunology
Antirheumatic Agents immunology
Arthritis, Rheumatoid blood
Arthritis, Rheumatoid immunology
Drug Substitution
Humans
Infliximab immunology
Rituximab immunology
Treatment Failure
Treatment Outcome
Adalimumab therapeutic use
Antibodies blood
Antirheumatic Agents therapeutic use
Arthritis, Rheumatoid drug therapy
Infliximab therapeutic use
Rituximab therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1532-866X
- Volume :
- 50
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Seminars in arthritis and rheumatism
- Publication Type :
- Editorial & Opinion
- Accession number :
- 31375255
- Full Text :
- https://doi.org/10.1016/j.semarthrit.2019.06.021